KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Cash from Financing Activities (2016 - 2026)

Edwards Lifesciences has reported Cash from Financing Activities over the past 17 years, most recently at -$11.4 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 139.86% year-over-year to -$11.4 million; the TTM value through Dec 2025 reached -$956.8 million, up 2.67%, while the annual FY2025 figure was -$956.8 million, 2.67% up from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$11.4 million at Edwards Lifesciences, up from -$740.1 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $61.7 million in Q1 2024 and troughed at -$976.7 million in Q3 2024.
  • A 5-year average of -$229.6 million and a median of -$120.0 million in 2023 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: plummeted 1252.26% in 2022 and later soared 154.55% in 2025.
  • Year by year, Cash from Financing Activities stood at -$62.0 million in 2021, then plummeted by 1252.26% to -$838.4 million in 2022, then surged by 50.72% to -$413.2 million in 2023, then skyrocketed by 106.92% to $28.6 million in 2024, then crashed by 139.86% to -$11.4 million in 2025.
  • Business Quant data shows Cash from Financing Activities for EW at -$11.4 million in Q4 2025, -$740.1 million in Q3 2025, and $52.7 million in Q2 2025.